Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral Neuropathy
By Elana Gotkine HealthDay Reporter
MONDAY, July 22, 2024 -- Neuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 in JAMA Internal Medicine.
Fiona Streckmann, Ph.D., from the University of Basel in Switzerland, and colleagues examined whether sensorimotor training (SMT) and whole-body vibration (WBV) training reduce symptoms and decrease onset of CIPN among patients undergoing treatment with oxaliplatin or vinca alkaloids. A total of 158 patients were randomly assigned into three groups: SMT (55 patients), WBV (53 patients), and treatment as usual (TAU; 50 patients).
The researchers found that the incidence of CIPN was significantly lower in SMT and WBV groups compared with TAU (30.0 and 41.2 percent, respectively, versus 70.6 percent) in intention-to-treat analysis. The most benefit was seen for patients receiving vinca alkaloids and performing SMT. In a per-protocol analysis, the results were more pronounced (28.6 and 37.5 percent, respectively, versus 73.3 percent). For balance control bipedal with eyes open, bipedal with eyes closed, monopedal, vibration sensitivity, sense of touch, lower leg strength, pain reduction, burning sensation, chemotherapy dose reductions, and mortality, improvements were seen in favor of SMT versus TAU.
"We were able to show that SMT can decrease CIPN, as well as maintain and improve subjective and objective outcomes, such as vibration sensitivity, sense of touch, lower leg strength, pain, burning sensation, and balance control," the authors write. "WBV showed a reduced incidence of CIPN and improved balance in a bipedal stance."
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Half of Young Cancer Patients Report Fertility Preservation Discussion With Provider
TUESDAY, Nov. 19, 2024 -- Many young patients with early-onset cancer report having a fertility preservation (FP) discussion with their health care professional prior to...
Barriers to Widespread Access to Cancer Medications Include Excessive Cost
TUESDAY, Nov. 19, 2024 -- Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review published online Nov. 18 in...
Omega-6 and Omega-3 Fatty Acid Levels Inversely Tied to Cancer Incidence
THURSDAY, Nov. 7, 2024 -- There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.